Shengnan Jia

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Chaolei Zhang · 4 shared papers, 2023–2026 · strength 0.92
   • Paper Filgotinib inhibits METTL3-mediated m6A of EIF3A by targeting ERG-TBP to suppress PDAC progression JAK-STAT3-independen… DOI 10.1038/s41698-026-01396-z↗
   • Paper Diagnostic plasma small extracellular vesicles miRNA signatures for pancreatic cancer using machine learning methods. DOI 10.1016/j.tranon.2023.101847↗
   • Paper Discovery of an 8-oxoguanine regulator PCBP1 inhibitor by virtual screening and its synergistic effects with ROS-modula… DOI 10.3389/fmolb.2024.1441550↗
2. Liping Cao · 4 shared papers, 2023–2024 · strength 0.86
   • Paper Fisetin disrupts mitochondrial homeostasis via superoxide dismutase 2 acetylation in pancreatic adenocarcinoma. DOI 10.1002/ptr.8296↗
   • Paper Diagnostic plasma small extracellular vesicles miRNA signatures for pancreatic cancer using machine learning methods. DOI 10.1016/j.tranon.2023.101847↗
   • Paper Discovery of an 8-oxoguanine regulator PCBP1 inhibitor by virtual screening and its synergistic effects with ROS-modula… DOI 10.3389/fmolb.2024.1441550↗
3. Xiaofan Pu · 3 shared papers, 2023–2026 · strength 0.70
   • Paper Filgotinib inhibits METTL3-mediated m6A of EIF3A by targeting ERG-TBP to suppress PDAC progression JAK-STAT3-independen… DOI 10.1038/s41698-026-01396-z↗
   • Paper Diagnostic plasma small extracellular vesicles miRNA signatures for pancreatic cancer using machine learning methods. DOI 10.1016/j.tranon.2023.101847↗
   • Paper Sirtuin4 impacts mitochondrial homeostasis in pancreatic cancer cells by reducing the stability of AlkB homolog 1 via d… DOI 10.1016/j.bbagrm.2023.194941↗
4. Kexiong Qiao · 2 shared papers, 2024–2026 · strength 0.52
   • Paper Filgotinib inhibits METTL3-mediated m6A of EIF3A by targeting ERG-TBP to suppress PDAC progression JAK-STAT3-independen… DOI 10.1038/s41698-026-01396-z↗
   • Paper Discovery of an 8-oxoguanine regulator PCBP1 inhibitor by virtual screening and its synergistic effects with ROS-modula… DOI 10.3389/fmolb.2024.1441550↗
5. Liangjing Zhou · 2 shared papers, 2024–2026 · strength 0.52
   • Paper Filgotinib inhibits METTL3-mediated m6A of EIF3A by targeting ERG-TBP to suppress PDAC progression JAK-STAT3-independen… DOI 10.1038/s41698-026-01396-z↗
   • Paper Discovery of an 8-oxoguanine regulator PCBP1 inhibitor by virtual screening and its synergistic effects with ROS-modula… DOI 10.3389/fmolb.2024.1441550↗
6. Yimin Ding · 1 shared paper, 2024 · strength 0.24
   • Paper Fisetin disrupts mitochondrial homeostasis via superoxide dismutase 2 acetylation in pancreatic adenocarcinoma. DOI 10.1002/ptr.8296↗
7. Dafei Xie · 1 shared paper, 2024 · strength 0.24
   • Paper Fisetin disrupts mitochondrial homeostasis via superoxide dismutase 2 acetylation in pancreatic adenocarcinoma. DOI 10.1002/ptr.8296↗
8. Tianshu Pang · 1 shared paper, 2024 · strength 0.22
   • Paper Diagnostic plasma small extracellular vesicles miRNA signatures for pancreatic cancer using machine learning methods. DOI 10.1016/j.tranon.2023.101847↗
9. Tao Shen · 1 shared paper, 2024 · strength 0.22
   • Paper Diagnostic plasma small extracellular vesicles miRNA signatures for pancreatic cancer using machine learning methods. DOI 10.1016/j.tranon.2023.101847↗
10. Dongnan Ping · 1 shared paper, 2023 · strength 0.18
    • Paper Sirtuin4 impacts mitochondrial homeostasis in pancreatic cancer cells by reducing the stability of AlkB homolog 1 via d… DOI 10.1016/j.bbagrm.2023.194941↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.